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ABSTRACT
Protein array technology is a powerful platform for the simultaneous 
determination of the expression levels of a number of proteins as well as post-
translational modifications such as phosphorylation. Here, we screen and report 
for the first time, the dominant signaling cascades and apoptotic mediators during 
the course of cadmium (Cd)-induced cytotoxicity in human bronchial epithelial cells 
(BEAS-2B) by antibody array analyses. Proteins from control and Cd-treated cells were 
captured on Proteome Profiler™ Arrays for the parallel determination of the relative 
levels of protein phosphorylation and proteins associated with apoptosis. Our results 
indicated that the p38 MAPK- and JNK-related signal transduction pathways were 
dramatically activated by Cd treatment. Cd potently stimulates the phosphorylations 
of p38α (MAPK14), JNK1/2 (MAPK8/9), and JUN; while the phosphorylations of 
Akt1, ERK1/2 (MAPK3/1), GSK3ß, and mTOR were suppressed. Moreover, there 
was an induction of proapoptotic protein BAX, release of cytochrome c (CYCS) from 
mitochondria, activation of caspase-3/9 (CASP3/9); as well as decreased expression 
of cell cycle checkpoint proteins (TP53, p21, and p27) and several inhibitors of 
apoptosis proteins (IAPs) [including cIAP-1/2 (BIRC2/3), XIAP (BIRC4), and 
survivin (BIRC5)]. Pretreatment of cells with the thiol antioxidant glutathione or 
p38 MAPK/JNK inhibitors before Cd treatment effectively abrogated ROS activation 
of p38 MAPK/JNK pathways and apoptosis-related proteins. Taken together, our 
results demonstrate that Cd causes oxidative stress-induced apoptosis; and the p38 
MAPK/JNK and mitochondrial pathways are more importantly participated for signal 
transduction and the induction of apoptosis in Cd-exposed human lung cells. 
INTRODUCTION
Toxic metal ions represent health threats to human 
lives. In particular, cadmium (Cd) is one of the important 
carcinogenic heavy metals that can persist in contaminated 
water, food and soil [1]. Cd is also present in cigarette 
smokes and airborne particles of polluted air [2, 3]. 
Studies of the last two decades have established that the 
effects of Cd are multifaceted and the cellular response 
to Cd is concentration-dependent and cell-type specific 
[4–6], which can lead to oxidative stress, promotion of 
cell proliferation, acquisition of apoptotic resistance, as 
well as malignant transformation [7–15]. Since lung is one 
of the susceptible organs prone to Cd-induced cytotoxicity 
and carcinogenicity [2], therefore, it becomes an urgent 
matter to understand more on the action mechanisms of 
Cd to the lungs.
In the past, although many studies have been 
conducted by scientists to examine the cellular response of 
cells challenged with Cd, yet, a more systematic approach 
for the determination of changes at post-translational 
levels (such as phosphorylation) is lacking [16–21]. 
Proteomics is a powerful tool to study many proteins in 
a single analysis. Therefore, in this study, we resolved to 
Oncotarget6147www.impactjournals.com/oncotarget
screen and report for the first time, the dominant signaling 
cascades and apoptotic mediators during the course of 
Cd-induced cytotoxicity in normal human bronchial 
epithelial cells (BEAS-2B) by antibody array analyses. 
Proteins from control and Cd-treated cells were captured 
on Proteome Profiler™ Arrays for the parallel determination 
of the relative levels of expression of a panel of 
phosphorylated proteins and proteins associated with 
apoptosis.
To this end, we identified the proteome changes 
associated with Cd induced cytotoxicity in human 
bronchial epithelial cells, including ROS activation of 
the p38 MAPK/JNK pathways and induction of proteins 
involved in intrinsic apoptosis. On the other hand, the key 
players of survival signaling pathways (Akt1 and ERK1/2) 
were suppressed and there were decreased expression of 
cell-cycle checkpoint proteins (TP53, p21 and p27) and 
several inhibitors of apoptosis proteins (IAPs), including 
cIAP-1/2, XIAP, and survivin. Pretreatment of cells with 
the thiol antioxidant glutathione (GSH) or p38 MAPK/JNK 
inhibitors before Cd treatment effectively abrogated ROS 
activation of p38 MAPK/JNK pathways and apoptosis-
related proteins. The implications of these findings are that 
Cd causes oxidative stress-induced cytotoxicity in human 
lung cells primarily through the p38 MAPK/JNK and 
mitochondrial pathways; and the differentially-expressed 
protein signatures could be considered for potential use as 
biomarkers upon Cd exposure.
RESULTS
The p38 MAPK- and JNK-related signal 
transduction pathways are dramatically 
activated by Cd treatment
From our previous study, we examined the 
cytotoxicity of CdCl2 in human bronchial epithelial cells 
(BEAS-2B) and showed that the lethal concentration range 
is around 20–30 µM post 36 h of CdCl2 treatment [22]. 
In this study, we therefore wish to examine the dominant 
signaling cascades and apoptotic mediators during the 
course of Cd-induced cytotoxicity. First, to dissect the 
early cellular response to Cd, BEAS-2B cells were 
sham-exposed or treated with 100 µM CdCl2 for 3 h 
(a higher concentration of Cd has been employed as in 
many studies to study early signaling events) [11, 12, 23]. 
After treatment, total cell extracts were isolated and 
subjected to human phospho-MAPK array analysis. 
Overall, the results indicated that the p38α (MAPK14) and 
JNK1/2 (MAPK8/9) showed the greatest fold of increase 
in phosphorylations (with MAPK14 increased 25.34-fold, 
MAPK8 10.93-fold, and MAPK9 8.31-fold), as compared 
with the untreated control (Figure 1). Other proteins which 
also showed increase of phosphorylations included CREB1 
(2.54-fold) and HSP27 (HSPB1) (1.98-fold). On the other 
hand, the phosphorylations of Akt1, mTOR, GSK3β, 
ERK1/2 (MAPK3/1), and RSK2 (RPS6KA3) were all 
significantly decreased (Figure 1; Supplementary Table S4).
Cd activates the p38 MAPK- and JNK-related 
signal transduction pathways in a  
time-dependent manner
To further identify the primary signal transduction 
pathway induced by Cd, we used a human phospho-
kinase array comprising 43 kinase phosphorylation sites, 
including also kinases from the phospho-MAPK array. 
This time, BEAS-2B cells were sham-exposed or treated 
with 30 µM CdCl2 for 6, 12, and 24 h. After treatment, 
total cell extracts were isolated and subjected to human 
phospho-kinase array analysis. As shown in Figure 2, 
again, the p38 MAPK- and JNK-related signal transduction 
pathways were strongly activated by Cd treatment 
(with MAPK14 increased 3.45-fold and MAPK8/9 2.85-
fold). HSPB1, CREB1 and JUN (c-Jun), which are well-
known substrates of p38 MAPK and JNK, were also 
dramatically elevated in phosphorylation upon Cd treatment 
(with HSPB1 increased 4.14-fold, CREB1 1.76-fold, 
and JUN 6.00-fold) (Figure 2). Consistent with the 
phospho-MAPK array results, some of the key players of 
survival signaling and energy metabolic pathways (p-Akt1, 
p-mTOR, p-EGFR and p-MAPK3/1), were significantly 
suppressed (Figure 2; Supplementary Table S5). 
Interestingly, we found that the phosphorylations of TP53 
at S15 and S46 (which are important phosphorylation 
sites for stress responses) were also decreased, whereas 
several of the STAT family members, including STAT3, 
STAT5A/B and STAT6, were all increased. Lastly, the 
levels of p-PRKAA2 (p-5ʹ-AMP-activated protein kinase 
catalytic subunit alpha-2), CTNNB1 (Catenin beta-1), and 
HSPD1 (HSP60) were also moderately increased, while 
the autophosphorylation levels of several tyrosine kinases 
like Src, Fyn, Hck, FAK1, as well as the phosphorylation 
levels of 40 kDa proline-rich Akt substrate (PRAS40), were 
moderately decreased (Figure 2; Supplementary Table S5).
To ensure if the altered phosphorylation in 
phospho-MAPK and phospho-kinase arrays are due to 
upstream regulation instead of simply due to altered 
protein amounts, we performed western blot analyses 
using the same cell lysates that were used for antibody 
array analyses (Supplementary Figure S1A). Our results 
indicated that among the majority of proteins with 
increased or decreased in phosphorylations, except for 
HSPB1 and TP53, most of them have no alteration in total 
protein levels, indicating that the altered phosphorylation 
is likely due to upstream regulation.
The effects of Cd exposure on apoptosis-related 
proteins in BEAS-2B cells
Next, we examined the apoptotic mediators that 
drive cell death in Cd-treated BEAS-2B cells. We 
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employed the human apoptosis array with 35 apoptosis 
related-proteins. BEAS-2B cells were sham-exposed 
or treated with 30 µM CdCl2 for 24 h, total cell extracts 
were isolated and then subjected to human apoptosis array 
analysis. As shown in Figure 3, the proapoptotic protein 
BAX and active caspase-3 (CASP3) were increased 
by 1.85-fold and 2.45-fold, respectively. Several other 
proteins were also induced, like catalase (CAT) (1.62-fold), 
clusterin (CLU) (2.11-fold), hypoxia-inducible factor 
1-alpha (HIF1A) (2.31-fold), and heme oxygenase 
1 (HMOX1) (2.38-fold). Interestingly, the expression of 
several inhibitors of apoptosis proteins (IAPs), including 
cIAP-1 (BIRC2), cIAP-2 (BIRC3), XIAP (BIRC4), and 
survivin (BIRC5), were significantly suppressed. Other 
proteins which showed significant suppression included 
claspin (CLSPN) [an essential replication checkpoint 
control protein], high temperature requirement protein 
A2 (HTRA2) [a serine protease that is involved in 
the degradation of aberrantly folded proteins during 
conditions of cellular stress], cyclin-dependent kinase 
inhibitor 1 (CDKN1A/p21), cyclin-dependent kinase 
inhibitor 1B (CDKN1B/p27), and tumor necrosis factor 
receptor superfamily member 1A (TNFRSF1A) (Figure 3; 
Supplementary Table S6). Again, to confirm the data from 
the apoptosis array analyses, we performed western blot 
analyses using the same cell lysates that were used for 
antibody array analyses (Supplementary Figure S1B). 
Our results indicated that similar trend of induction or 
Figure 1: The p38 MAPK/JNK (MAPK14 or MAPK8/9) signaling pathways are strongly activated by Cd treatment in 
BEAS-2B cells. Protein extract (300 µg) were used for phospho-MAPK array analysis. Array spots were visualized in accordance with 
the manufacturer’s instructions. The intensity of each spot was measured as described in “Materials and Methods”. The graph shows the 
relative fold change of proteins with significant difference upon Cd treatment, setting 1 for control (no treatment of Cd). Protein levels with 
higher than ± 2 folds (i.e.  2 or  0.5 as indicated by dotted lines) are considered as candidates that are more importantly participated in 
the Cd toxicity pathway. The data are shown as an average of two individual sets of sample.
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repression can be observed as they appeared in antibody 
array analyses, suggesting that the data from apoptosis 
arrays are reliable.
Induction of proapoptotic protein BAX and the 
loss of mitochondrial transmembrane potential 
in Cd-treated BEAS-2B cells
Since 30 µM CdCl2 treatment induced cell death 
in BEAS-2B cells with the induction of proapoptotic 
BAX (from human apoptosis array results), we therefore 
would like to check the integrity of mitochondria. We 
used the JC-1 Mitochondria Apoptosis Detection Kit 
which can distinguish healthy and apoptotic cells by 
detecting the loss of the mitochondrial transmembrane 
potential (∆ψ). BEAS-2B cells were sham-exposed 
or dosed with 30 µM CdCl2 for 18 h. JC-1 assay was 
conducted as described in Materials and Methods for the 
determination of mitochondrial membrane integrity. As we 
can see in Figure 4A, JC-1 aggregates (red colors) were 
robustly observed in control cells which indicate cells 
are healthy and with an intact mitochondrial potential. 
However, for Cd-treated cells, the red colors were visibly-
diminished, suggesting the collapses of mitochondrial 
potential, and JC-1 dye is no longer accumulated 
within the mitochondria, but dispersed to the cytoplasm 
(green colors). To further verify the results from apoptosis 
array that BAX is induced upon Cd treatment, BEAS-2B 
Figure 2: The p38 MAPK/JNK (MAPK14 or MAPK8/9) signaling pathways and c-Jun are strongly activated by 
Cd treatment in a time-dependent manner. Protein extract (600 µg) were used for phospho-kinase array analysis. Array spots 
were visualized in accordance with the manufacturer’s instructions. The intensity of each spot was measured as described in “Materials 
and Methods”. The graph shows the relative fold change of proteins with significant difference upon Cd treatment, setting 1 for control 
(no treatment of Cd). Protein levels with higher than ± 2 folds (i.e.  2 or  0.5 as indicated by dotted lines) are considered as candidates that 
are more importantly participated in the Cd toxicity pathway. The data are shown as an average of two individual sets of sample.
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cells were sham-exposed or dosed with increasing 
concentrations of CdCl2 for 36 h; cells were lysed; and 
protein extracts were subjected to western blot analysis 
using antibodies against BAX (Figure 4B). The results 
indicated that BAX is induced in a dose-dependent 
manner, which would likely accelerate programmed cell 
death by binding to mitochondrion membrane, leading to 
the release of cytochrome c (CYCS), promoting activation 
of caspases, and triggering apoptosis.
Inhibition of oxidative stress by GSH abrogated 
the activation of Cd-induced p38/JNK pathways 
and proteins involved in apoptosis signaling
To determine whether the data from kinase array 
analyses were reliable, we used the same cell lysate 
for western blot analysis. As shown in Figure 5A, 
treatment of BEAS-2B cells with 30 µM of CdCl2 
induced the activation of p38 MAPK, JNK and c-Jun in a 
time-dependent manner. Moreover, we checked the 
expression levels of other important apoptosis mediators 
that covered in the apoptosis array by western blot analysis 
[we also performed on caspase-9 (CASP9) and poly 
[ADP-ribose] polymerase 1 (PARP1) as they were not 
included in the format of protein arrays]. In the previous 
section, although the results from apoptosis array showed 
that there is no difference in CYCS levels between control 
and Cd-treated cells, however, we wonder that possibly 
because of no prior subcellular fractionation (just a whole 
cell lysate analysis), which didn’t address whether there 
is release of CYCS from mitochondria to the cytosol. 
Therefore, we performed subcellular fractionation and 
examine again the level of CYCS. This time, we can see 
that indeed CYCS is increased in the cytosolic fraction 
upon Cd treatment (Figure 5B). The induction/cleavage 
of BAX/CYCS/CASP9/CASP3/PARP1 can well be 
Figure 3: Alterations of apoptosis-related proteins in Cd-treated BEAS-2B cells. Protein extract (400 µg) were used for 
apoptosis array analysis. Array spots were visualized in accordance with the manufacturer’s instructions. The intensity of each spot was 
measured as described in “Materials and Methods”. The graph shows the relative fold change of proteins with significant difference upon 
Cd treatment, setting 1 for control (no treatment of Cd). Protein levels with higher than ± 2 folds (i.e.  2 or  0.5 as indicated by dotted 
lines) are considered as candidates that are more importantly participated in the Cd toxicity pathway. The data are shown as an average of 
two individual sets of sample.
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observed, suggesting that Cd-induced apoptosis is likely 
executed through the intrinsic mitochondrial pathway.
Our previous study reported that Cd-induced 
cytotoxicity through oxidative stress and along with the 
expression of a panel of stress/defense proteins, and the Cd-
induced cytotoxicity can be blocked by pretreating the cells 
with the thiol antioxidant GSH [22, 24]. Therefore, we 
investigated the protective ability of intracellular GSH in 
the induction/repression of some of the important proteins 
that we identified in this study. First, we further proved 
that Cd-induced oxidative stress is due to ROS generation, 
as we can see that treatment with CdCl2 resulted in 
a rapid elevation of ROS generation in BEAS-2B 
cells as early as 30 min-treatment (Supplementary 
Figure S2). As shown in Figure 5, pretreatment of cells 
with GSH efficiently abrogated the activation of p38 
MAPK, JNK, and c-Jun (Figure 5A, lane 5), moreover, 
the same trend also occurred to BAX, CYCS, CASP9, 
CASP3, and PARP1, in which their induction or cleavage 
are blocked by GSH pretreatment (Figure 5B, lane 5). 
Inhibition of Cd-induced p38/JNK activity by 
specific kinase inhibitors, SB203580 and JNK 
inhibitor VIII
To show that a high level of Cd exposure induces the 
p38/JNK pathways and leads to apoptosis, BEAS-2B cells 
were left untreated or pretreated with 20 µM SB203580 
or 40 µM JNK inhibitor VIII for 1 h before exposure to 
30 µM Cd for 24 h. They were then subjected to western 
blot analysis for the levels of BAX, CASP9, and CASP3. 
30 µM Cd treatment stimulated BAX, active CASP9 
Figure 4: Cd treatment induced the loss of mitochondrial transmembrane potential and the up-regulation of 
proapoptotic protein BAX. (A) BEAS-2B cells were sham-exposed or dosed with 30 µM CdCl2 for 18 h. JC-1 assay was conducted as 
described in “Materials and methods” for the determination of mitochondrial membrane integrity. (B) BEAS-2B cells were sham-exposed 
or dosed with increasing concentrations of CdCl2 for 36 h; cells were lysed; and protein extracts were subjected to western blot analysis 
using antibodies against BAX. The same blot was stripped and reprobed with the monoclonal β-actin antibody to monitor the loading 
difference. The results are representative of three independent experiments.
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and CASP3, compared with controls (Figure 6A). This 
stimulation can be blocked by SB203580/JNK inhibitor 
VIII (although not as effective as by GSH pretreatment). 
In the absence of p38/JNK inhibitor pretreatment, massive 
cytotoxicity can be observed by Cd treatment (Figure 6B). 
These results suggest that cell death correlates with 
Cd-induced p38/JNK activity in BEAS-2B cells. 
Altogether, these data confirm that the p38 MAPK and 
JNK signaling pathways are critical for mediating the 
ROS stress signal exerted by Cd. Also, the mitochondrial 
pathway accelerates programmed cell death, due to 
the release of CYCS and the subsequent activation of 
CASP9/3, and the execution of cleavage of a variety of 
caspase substrates, including PARP1; which are key 
indicators of intrinsic apoptosis.
DISCUSSION
In the past, many studies have been conducted 
to examine the cellular response of cells challenged 
with toxic metal(s), however, to our knowledge, a more 
systematic approach for the determination of changes 
at post-translational levels (such as phosphorylation) is 
lacking [16–21]. Therefore, it is important to further study 
the cellular effects at post-translational levels with the aim 
of identifying proteins whose activities are specifically 
modified by toxic metal exposure. For instance, most 
kinase signaling pathways are stimulated rapidly by post-
translational modifications, such as phosphorylation of 
downstream proteins and effectors; while many other 
proteins are controlled by proteolytic cleavage (such as 
Figure 5: GSH inhibited the activation of Cd-induced p38 MAPK/JNK pathways and proteins involved in apoptosis 
signaling. BEAS-2B cells were sham-exposed or dosed with 30 µM CdCl2 for 6, 12, or 24 h (A) or with 30 µM CdCl2 for 24 or 36 h 
(B); cells were lysed; and protein extracts were subjected to western blot analyses using antibodies against p-p38 MAPK, p38 MAPK, 
p-JNK, JNK, p-c-Jun, c-Jun, Bax, Cytochrome c, Caspase-9, Caspase-3, and PARP1. Cells were also pretreated with 20 mM GSH for 1 h 
before exposed to 30 µM CdCl2 for 24 (A) or 36 h (B). The same blot was stripped and reprobed with the monoclonal β-actin antibody to 
monitor the loading difference. The results are representative of three independent experiments.
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caspases) and the subcellular localization of proteins are 
critical determinants of their cellular activities. All these 
cannot be determined merely at transcriptional levels.
In this study, we resolved to screen and report for the 
first time, the dominant signaling cascades and apoptotic 
mediators during the course of Cd-induced cytotoxicity 
in normal human bronchial epithelial cells (BEAS-2B) 
by antibody array analyses. Proteins from control and 
Cd-treated cells were captured on Proteome Profiler™ 
Arrays for the parallel determination of the relative levels 
of expression of a panel of phosphorylated proteins and 
proteins associated with apoptosis. This would hopefully 
provide a better understanding of the mechanisms of 
action of Cd and allow development of sensitive and 
specific biomarkers of both exposure and susceptibility 
for use in both mechanistic and epidemiological studies. 
However, we want to emphasize for the fact that currently 
there is no corresponding expression-array available for 
this commercial phospho-kinase array, therefore, whether 
the altered phosphorylation is due to upstream regulation 
or simply due to altered protein amounts is uncertain. To 
this end, we therefore performed western blot analyses 
using the same cell lysates that were used for protein 
array analyses on most of the major proteins that showed 
significant difference between control and Cd-treatment 
(Supplementary Figure S1A). Our results indicated that 
among the majority of proteins with increased or decreased 
in phosphorylations, except for TP53 and HSPB1, most of 
Figure 6: Cd-induced p38/JNK activity correlates with cell death. BEAS-2B cells were left untreated or pretreated with 20 µM 
SB203580 or 40 µM JNK inhibitor VIII for 1 h before exposure to 30 µM CdCl2 for 24 h. They were then subjected to (A) western blot 
analysis to detect the levels of Bax, Caspase-9, and Caspase-3. The same blot was stripped and reprobed with the monoclonal β-actin 
antibody to monitor the loading difference. (B) The corresponding cell morphology of BEAS-2B cells under light microscope. The results 
are representative of three independent experiments; SB, SB203580; JNKi VIII, JNK inhibitor VIII.
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them have no alteration in total protein levels, indicating 
that the altered phosphorylation is likely due to upstream 
regulation.
Although it is likely that the decreased phosphor-
ylation levels (S15 and S46) of TP53 observed in protein 
array experiments are merely due to reduced expression 
of TP53, no matter how, we believe that the total protein 
amount of TP53 is obviously decreased significantly. The 
consequence of p53 under-expression is significant as p53 
is the principal guardian in maintaining genome stability 
such that reduced or diminished p53 could then lead to 
defects in cell cycle check points and DNA repair. As a 
matter of fact, our western blot analysis also confirmed 
the decreased expression of p21 and p27 in Cd-treated 
cells, which may further render the cells deficient in 
cell cycle arrest for proper repair. For HSPB1, it is well 
documented that its protein and phosphorylation levels are 
increased during stress condition; in our cell model, the 
increased phosphorylation levels (S78 and S82) of HSPB1 
observed in phospho-MAPK and phospho-kinase arrays 
are likely due to up-regulation of HSPB1 protein amount, 
since we also observed the increase of HSPB1 protein 
level in apoptosis array and western blot analysis. For 
HSPD1, it is implicated in mitochondrial protein import 
and macromolecular assembly, its elevation may prevent 
misfolding and promote the refolding and proper assembly 
of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix.
By analyzing the protein list in IPA® database, 
we are able to examine their relationships in details and 
summarize the more importantly participated signaling 
molecules and apoptotic mediators in this study. For a 
better visualization of the results, we basically clustered 
the stimulated/activated proteins (red colors) on the left 
half while inhibited/suppressed proteins (green colors) on 
the right half as shown in Figure 7. So, upon Cd insults, 
oxidative stress arises from ROS generation, which 
activates the p38 MAPK- and SAPK/JNK- signaling and 
related downstream cascades and stimulates stress gene 
expressions. The upregulation of antioxidant enzyme CAT 
in cells served to remedy the imbalance of redox status by 
degrading superoxide radicals. HMOX1 was also induced, 
it has been reported that HMOX1 is highly inducible by its 
substrate heme and by various non-heme substances such 
as heavy metals, growing evidence shows that HMOX1 
can exert antiproliferative and antiapoptotic effects and 
participate in general cellular defense mechanism against 
oxidative stress in mammalian cells [25, 26]. Our data are 
in agreement with previous reports which demonstrated 
oxidative stress-induced CAT and HMOX1 up-regulations 
in human BEAS-2B and rat lung epithelial cells [27, 28]. 
Meanwhile, the expression of CLU was also significantly 
elevated in Cd-treated BEAS-2B cells. The function of 
CLU in promotion of cell death has been demonstrated 
in cultured mouse seminiferous tubules [29]. However, 
it has also been shown that mitochondrial CLU isoforms 
suppress BAX-dependent release of CYCS into the 
cytoplasm and inhibit apoptosis [30]. Nevertheless, if the 
intracellular detoxification/anti-apoptosis/survival system 
cannot cope with the detrimental effects exerted by Cd, 
apoptotic cascade has to be inevitably activated in order 
to eliminate damaged cells. Our data showed that the 
proapoptotic protein BAX is stimulated in BEAS-2B cells 
dosed with Cd. We also demonstrated that CYCS is release 
to the cytosol (CYCS release is a key indicator of intrinsic 
apoptosis). The upregulation of BAX and release of CYCS 
led to mitochondrial dysfunction (as supported by JC-1 
assay on loss of mitochondrial potential); causing gradual 
Figure 7: Bioinformatic analyses of differentially-expressed proteins from BEAS-2B cells dosed with Cd. Proteins 
involved in cell death of epithelial cells were classified by Diseases and Bio Functions Annotation from Ingenuity® Pathway Analysis. Red 
and green colors represent stimulated or inhibited protein expressions/activities, respectively. For CASP9, CASP3 and PARP1, red colors 
indicate an increase of their cleavage products. Canonical Pathway (CP) and Ingenuity® Tox List (Tx) were also annotated (solid blue lines) 
to indicate the specific pathway/related biological process among these proteins.
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failure of energy powerhouse of the cells, and subsequently 
activated the cleavage of CASP9/3 and PARP1. On the 
other hand, the expressions of cell cycle checkpoint 
(G1/S or G2/M) proteins, like TP53, p21 and p27 are all 
suppressed, which may likely making cells deficient in 
cell cycle arrest for proper repair. Also, the suppressed 
expression of TNFRSF1A may lead to inhibition 
of cell survival [31]. Moreover, the phosphorylations 
of several key players in cell survival and energy 
metabolic pathways (Akt1, mTOR, GSK3β and MAPK1) 
as well as the expressions of inhibitors of apoptosis 
proteins (BIRC2/3/4/5) were all diminished, all these 
events finally contributed to the cell death of BEAS-2B 
lung cells.
Although the IPA® analysis cannot provide a 
plausible relationship of various STATs (STAT3/5A/5B/6) 
and HIF1A to cell death of normal human bronchial 
epithelial cells that we reported here, we are of the 
opinion that they may also be important factors that are 
involved during the course of Cd-induced apoptosis. It 
has been shown that chronic low concentrations of Cd 
exposure increases HIF1A and VEGF expression through 
ROS, ERK, and Akt signaling pathways and induces 
malignant transformation of human bronchial epithelial 
cells [32], and Cd induced STAT3 activation in HepG2 
cells and STAT1/3 phosphorylations in renal proximal 
tubular epithelial cells [33, 34]. However, no reports have 
indicated so far for Cd’s effects on the phosphorylations 
of STAT5A/B and STAT6, which warrant further 
investigation. Suffice to say, our data showed that the 
ROS generation and activation of p38 MAPK- and 
JNK-related signal transduction pathways are vital in 
mediating Cd-induced apoptosis in normal human lung 
cells. Since pretreatment of GSH or p38/JNK inhibitors 
prior to Cd effectively abrogated the activation of p38 
MAPK/JNK pathways and apoptosis-related proteins in 
this cell type. Besides, the emergence of mitochondrial 
dysfunction, deficiency of cell cycle checkpoint proteins, 
decreased expression of IAPs and diminished survival 
signaling are also critical which finally contributed to the 
death fate of BEAS-2B epithelial cells (Figure 7).
In conclusion, we have presented a more global and 
updated picture of Cd-induced apoptosis in normal human 
lung cells. Our study also demonstrated the competency 
of antibody array technology in toxicological research, 
which might hopefully identify potential biomarkers and 
lead to the development of agents that can antagonize the 
cytotoxic effects exerted by toxicants.
MATERIALS AND METHODS
Materials
Cadmium chloride (CdCl2) was purchased from 
Sigma Aldrich (St. Louis, MO). The p38 MAPK inhibitor 
SB203580 (sc-3533) was purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). The JNK inhibitor 
VIII (# 15946) was purchased from Cayman Chemical 
(Ann Arbor, MI). The Human Phospho-MAPK, Human 
Phospho-Kinase, and Human Apoptosis Array Kits were 
obtained from R & D Systems (Minneapolis, MN). The 
Subcellular Protein Fractionation Kit for Cultured Cells 
was from Thermo Scientific (Rockford, IL). All other 
general chemicals were purchased from GE Healthcare 
(Uppsala, Sweden) and Sigma Aldrich. Antibodies 
used for western blot were purchased from Santa Cruz 
Biotechnology, GeneTex (Irvine, CA), Cell Signaling 
Technology (Danvers, MA) and Sigma Aldrich, with 
the following dilutions: p-p38 MAPK (4511; Cell 
Signaling Technology), 1:1000; p38 MAPK (8690; Cell 
Signaling Technology), 1:1000; p-JNK (sc-293138; 
Santa Cruz Biotechnology), 1:1000; JNK (sc-7345; Santa 
Cruz Biotechnology), 1:1000; p-c-Jun (sc-822; Santa 
Cruz Biotechnology), 1:1000; c-Jun (sc-1694; Santa Cruz 
Biotechnology), 1:1000; Bax (GTX109683; GeneTex), 
1:1000; Cytochrome c (11940; Cell Signaling Technology), 
1:1000; Caspase-9 (GTX112888; GeneTex), 1:1000; 
Caspase-3 (GTX110543; GeneTex), 1:1000; PARP1 
(GTX100573; GeneTex), 1:1000; Akt (GTX121937; 
GeneTex), 1:1000; BCL-2 (GTX127958; GeneTex), 
1:1000; BIRC2 (GTX110087; GeneTex), 1:1000; Catalase 
(GTX110704; GeneTex), 1:500; Clusterin (GTX101236; 
GeneTex), 1:800; ERK1/2 (sc-292838; Santa Cruz 
Biotechnology), 1:1000; GSK3β (GTX111192; GeneTex), 
1:1000; HIF1A (GTX127309; GeneTex), 1:800; HMOX1 
(GTX101147; GeneTex), 1:800; HSPB1 (GTX101145; 
GeneTex), 1:1000; mTOR (GTX101557; GeneTex), 
1:1000; p21 Cip1 (GTX100444; GeneTex), 1:800; p27 
Kip1 (GTX100446; GeneTex), 1:800; STAT5 (sc-835; 
Santa Cruz Biotechnology), 1:600; STAT6 (GTX113273; 
GeneTex), 1:1000; TNFRSF1A (GTX102718; GeneTex), 
1:1000; TP53 (sc-6243; Santa Cruz Biotechnology), 
1:1000; XIAP (GTX113130; GeneTex), 1:200; and 
β-Actin (A5441; Sigma Aldrich), 1:10000.
Cell culture
The human bronchial epithelial cell line (BEAS-2B) 
was purchased from the American Type Culture Collection 
(ATCC) (Rockville, MD). BEAS-2B cells were isolated 
from normal human bronchial epithelium obtained from 
autopsy of a non-cancerous individual. Cells were routinely 
grown in LHC-9 medium (Gibco, Grand Island, NY) 
at 37°C in an atmosphere of 5% CO2/95% air as recom-
mended by ATCC. LHC-9 is a defined, serum-free 
medium which is prepared by mixing LHC basal medium 
with growth factors, cytokines, and supplements; and has 
been described previously [35].
Cd treatment
Cells were grown to 75% confluence in 60 mM cell 
culture dishes and then rinsed with Hank’s balanced salt 
solution (HBSS) before they were either sham-exposed 
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or treated with different concentrations of CdCl2 in 
LHC-9 medium. Cells were pretreated with GSH or p38 
MAPK/JNK inhibitors for 1 h before the addition of Cd.
Cell lysate preparation
After treatment, cells were rinsed with PBS and 
extracted with Lysis buffer 6 (provided in the Human 
Phospho-MAPK and Human Phospho-Kinase Array Kit) 
or Lysis buffer 17 (provided in the Human Apoptosis 
Array Kit). After incubating and rocking at 4°C for 30 min, 
the samples were centrifuged at 14,000 g for 5 min, 
supernates were transferred into clean tubes and subjected 
to protein quantification. For subcellular proteins 
preparation, the cytosolic fraction was prepared using the 
Subcellular Protein Fractionation Kit for Cultured Cells in 
accordance with the manufacturer’s instructions.
Protein array analysis
Analysis of proteins by Human Phospho-MAPK, 
Human Phospho-Kinase and Human Apoptosis Arrays 
was conducted following the manufacturer’s instructions. 
In brief, protein sample was incubated with each array at 
4°C overnight on a rocking platform shaker. The unbound 
proteins were removed, and the arrays were washed three 
times with washing buffer. Arrays were incubated with 
the primary antibody solution for 2 h at room temperature 
and then washed three times with washing buffer. The 
secondary antibody solution was then added to the arrays 
on a rocking platform shaker for 1 h. The arrays were 
washed three times with washing buffer, and protein spots 
were visualized using the chemiluminescence detection 
reagents supplied in the Array Kits. The intensity score of 
each duplicated array spot was measured with the ImageJ 
(version 1.37v) software program, and the averaged 
intensity was calculated by subtracting the averaged 
background signal. The fold change was obtained by 
comparing Cd-treated samples with the untreated control 
(indicated as a value of 1). The identity and the respective 
coordinates of all the antibodies on the arrays can be found 
in “Supplementary Material”.
Conditions of western blot
For western blot analysis, equal amounts of 
proteins were fractionated on appropriate percentage of 
SDS–polyacrylamide gel and transferred onto 
polyvinylidene difluoride membranes. After the transfer, 
the membranes were blocked with 5% nonfat dry milk 
in PBS containing 0.05% Tween 20 and probed with 
various primary antibodies. After incubation with 
secondary antibodies, immunoblots were visualized 
with the enhanced chemiluminescence detection kit (GE 
Healthcare). Reproducibility was confirmed in three 
separate experiments and representative data were shown.
Fluorescence microscopy
The Mitochondria Apoptosis Detection Kit (JC-1) 
was purchased from GenScript (Piscataway, NJ). 
This Kit provides a simple, fluorescent-based method 
for distinguishing between healthy and apoptotic 
cells by detecting the loss of the mitochondrial 
transmembrane potential (∆ψ). The kit utilizes the 
unique lipophilic cationic dye (5, 5′, 6, 6′-tetrachloro-1, 
1′, 3, 3′-tetraethylbenzimidazolylcarbocyanine iodine, 
commonly known as JC-1) for detection. In healthy cells, 
the negative charge established by the intact mitochondrial 
membrane potential allows the lipophilic dye, bearing a 
delocalized positive charge, to enter the mitochondrial 
matrix where it accumulates. With the increasing of 
the concentration of JC-1, it aggregates and becomes 
fluorescent red. When the mitochondrial potential 
collapses in apoptotic cells, JC-1 just exists as monomers 
and do not accumulate within the mitochondria. When 
dispersed in this manner, JC-1 remains in the cytoplasm 
in a green fluorescent monomeric form. The fluorescent 
signals were examined by laser-scanning confocal 
microscopy (OLYMPUS FV1000), using FITC channel 
for green monomers and PI channel for red aggregates. 
Reproducibility was confirmed in three separate 
experiments and representative data were shown.
Measurement of ROS generation
ROS levels were determined by incubating the 
cells in LHC-9 media with 2 µM dihydroethidium 
(DHE, Molecular Probes) for 30 min at 37°C. Cells were 
washed three times with DPBS and replaced with new 
LHC-9 media, and then treated with 30 or 100 µM CdCl2 
for different time. After treatment, cells were trypsinized 
and fluorescence was measured using BD Accuri™ C6 
flow cytometer with excitation and emission wavelengths 
at 535 nm and 610 nm, respectively.
Bioinformatic analyses
Differentially-stimulated/inhibited proteins were 
listed and the data were analyzed through the use of 
QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN 
Redwood City, www.qiagen.com/ingenuity), to highlight 
the relationships among candidate proteins using networks 
and canonical pathways. Ingenuity Knowledge Base, 
the core behind IPA®, provides a wide range of high-
quality detailed information, including direct and indirect 
protein interaction networks, thus aiding the generation 
of hypotheses for a comprehensive analysis of a large 
number of data.
Data analysis
For antibody array analysis, protein levels with 
differences of higher than ± 2 folds (i.e.  2 or  0.5) 
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are considered as candidates that are more importantly 
participated in the Cd toxicity pathway.
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